IP 466 Pill: white, capsule/oblong, 19mm
The pill with imprint IP 466 (White, Capsule/Oblong, 19mm) has been identified as Ibuprofen 800 mg and is used for Back Pain, Chronic Myofascial Pain, Chronic Pain, Aseptic Necrosis, and Pain. It belongs to the drug class Nonsteroidal anti-inflammatory drugs and is not a controlled substance.
Images for IP 466
Ibuprofen
- Imprint
- IP 466
- Strength
- 800 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0339 (Discontinued) | AvKare, Inc. |
| 53746-0466 (Discontinued) | Amneal Pharmaceuticals LLC |
| 63739-0691 (Discontinued) | McKesson Packaging Services |
| 68084-0772 (Discontinued) | Amerisource Health Services |
| 54569-0289 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
| 54569-3332 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
| 66267-0118 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
See also:
More about ibuprofen
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (242)
- Drug images
- Latest FDA alerts (14)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Patient resources
- Ibuprofen drug information
- Ibuprofen injection
- Ibuprofen (Intravenous) (Advanced Reading)
- Ibuprofen lysine (Advanced Reading)
Other brands
Advil, IBU, A-G Profen, Addaprin, ... +20 more
Professional resources
- Ibuprofen monograph
- Ibuprofen (FDA)
- Ibuprofen 800mg (FDA)
- Ibuprofen Capsules (FDA)
- Ibuprofen Immediate Release Tablets (FDA)
Other brands
Advil, Motrin, IBU, Advil Liqui-Gels, ... +8 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.